Experimental NOTCH pathway inhibition as well as HES1 knockdown reduced oncogenic capacities in vitro, suggesting that the NOTCH pathway triggers oncogenic rather than tumor suppressive processes in T2E+ PCa. This evidence concerns the gene HES1 and neoplasm.